Dr. Reddy's Allots 10,275 Shares Under ESOPs on March 12, 2026
Dr. Reddy's Laboratories allotted 10,275 equity shares on March 12, 2026, under its ESOP schemes. This issuance brings the total issued shares to 83,46,54,295, with a total issued share capital of ₹83,46,54,295.
The issuance of a small number of shares under an employee stock option plan is a standard corporate action and is unlikely to have a significant impact on the company's overall market capitalization or valuation.
The allotment of shares under an ESOP scheme is a routine event and does not significantly impact the company's financial performance or stock price in a material way.
Dr. Reddy's Laboratories Limited has allotted 10,275 equity shares of Re.1/- each, fully paid up, on March 12, 2026. This allotment is pursuant to the exercise of stock options by eligible employees under the Dr. Reddy’s Employees Stock Options Scheme, 2002, and Dr. Reddy’s Employees ADR Stock Options Scheme, 2007.
Following this allotment, the company's total issued shares have increased to 83,46,54,295. The total issued share capital now stands at ₹83,46,54,295/-. The newly issued shares are identical in all respects to the existing shares and rank pari passu.
Details provided as per Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, confirm the nature of the security, par value, number of shares issued, and the distinctive numbers. The exercise price per share was Re.1/-, with no premium.
What to do with a filing like this
Dr. Reddy's Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under other company updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dr. Reddy's Laboratories Limited. Read the original for the full detail.